Macro Helix uses your pharmacy data to generate reports.

Yes. Our software includes features that allow you to customize reports, or you can choose from standardized reports for convenience.

Contact your account representative and we’ll see if there’s a way to generate the report you need; or, we may add it to our list for possible future development.

Yes, health systems that have central inventory sites for mixed use or owned outpatient pharmacies do need to utilize Macro Helix’s 340B Architect for split billing and/or contract pharmacy administration to access the Macro Helix 340B Central Split module.

There is no Macro Helix requirement regarding the type of central inventory. We work with several clients who house inventory in a larger owned pharmacy (mixed use or outpatient owned) for their health system’s smaller pharmacies to access.

Macro Helix was one of, if not the first company, to develop and offer a central split solution for health systems. We have several clients utilizing this module within 340B Architect today.  Our sales team is available to discuss with you and your team the several significant differentiators between the Macro Helix’s Central Split module and competitors.

Yes, Macro Helix provides ongoing education, consultation and collaboration with our customers.

Yes, our 340B audit monitoring team will assist you with HRSA and manufacturer audits.

Yes, Macro Helix’s software developers, in partnership with our compliance team and product managers, work together to address and add ongoing enhancements to application functionality based on changes with the 340B program and customer input.

Yes, our 340B Architect software is customizable to your organization's needs so you can design or modify your Community Prescription Assistance.

Yes, our team is highly knowledgeable about 340B programs and how health systems, hospitals, clinics and retail pharmacies can better serve their patients. We can help you understand how to use 340B Architect to design a customized Community Prescription Assistance.

340B Architect supports 340B compliance standards. Macro Helix also offers audit services to help your organization prepare for audits and mitigate risk.

No, you must be a McKesson pharmacy management system user to use Macro Helix solutions.

340B contract pharmacies benefit from Macro Helix solutions by improving their overall operations, maintaining compliance and better serving vulnerable patients.

Yes, Macro Helix's experts can help you identify the best way to engage with covered entities and become a part of their qualified network of retail pharmacy providers.

RxCorrelate is part of 340B Architect; it's an intelligent module that helps to identify prescriptions that may have resulted from a referral to an outside provider.

Yes, but we recommend health systems consult with their legal and compliance teams.

Yes. RxCorrelate, our referral capture solution, is an intelligent module of 340B Architect.

You can arrange an on-site audit preparation meeting through your account representative.

Our team has deep industry knowledge and has developed checklists based on what we know are standard auditable areas of your business.

Yes. We review your organization and pharmacy’s 340B-relevant policies as part of audit preparation.

If you are participating in the 340B federal drug pricing program, you should explore using Macro Helix’s solutions to help make sure you are getting contracted pricing on medications your patients need, or add manufacturers to your exclusion list.

If your organization uses 340B Architect, the 340B Validate solution is already built into the software. All you need to do is opt-in to use this discreet data validation service.

Yes, Macro Helix can assist in aligning your program with the most effective pharmacies for your network based upon geographic and script count/revenue potential criteria. Macro Helix will work directly with the potential pharmacy partners to project potential 340B claims and estimated program revenue. Macro Helix can also assist with certain PSA discussions with the pharmacy on your behalf.

Yes, a 340B contract pharmacy network can be a very effective program in funding your patient care programs as well as dispensing medications to your patients who cannot afford their PBM cost share, or have no insurance. Macro Helix can analyze the potential pharmacy partners to your program and conservatively estimate results based upon each individual manufacturer set of program restrictions.

Macro Helix can walk you through the transition process and provide you with information specific to your situation so you can make informed decisions.

We have the resources and staff to onboard new customers easily and to troubleshoot any issues with our large implementation and support teams. Our implementation team alone is bigger than most other TPAs’ entire headcount. Best of all, we charge no implementation fees.

Our customers have unparalleled availability to raw data from their 340B program, which they can use to evaluate results and make informed drug purchasing decisions. Our detailed reporting and advanced analytics capabilities are the best in the industry—and they’re available to you on-demand.

Cybersecurity is of paramount importance to us, and our customers benefit from an ultra-sophisticated approach, as McKesson’s data security measures overlay our Macro Helix system for added protection. It’s just one more way that we go above and beyond for you.

Macro Helix uses your pharmacy data to generate reports.

Yes. Our software includes features that allow you to customize reports, or you can choose from standardized reports for convenience.

Contact your account representative and we’ll see if there’s a way to generate the report you need; or, we may add it to our list for possible future development.

In addition to our top-notch software solutions—which automate many 340B tasks while improving financial performance, efficiency and compliance—what sets us apart is our high-touch customer relationship and support. We are your expert resource and true partner, every step of the way.

With Macro Helix you get the best of both worlds: the agility and service of a small firm, and access to the vast resources of McKesson. Those strengths and resources help us innovate and act progressively while avoiding a lot of risk. We pass that knowledge to our clients so they can thrive in today’s ever-changing environment.

Macro Helix’s services and system are designed around user needs. Our system is designed to provide our clients of all sizes with the functionality needed to run a successful, compliant program. Macro Helix services provide all clients program assistance including system training, program result reporting, crosswalk match, accumulation auditing, program compliance and audit, orphan drug management and contract pharmacy optimization. Macro Helix understands that all 340B programs are unique, but there is one commonality – the need for a user-friendly system that reduces manual work, allowing you to handle other responsibilities and patient care.

Macro Helix works with ALL distribution partners both with EDI and ongoing personal relationships and communications. Given this, our client base is made up of large health systems, standalone hospitals and clinics that utilize all three large distribution partners. We are, however, proud to be owned by McKesson Corporation. This ownership means that Macro Helix is an extremely stable TPA in a very turbulent industry.  This stability benefits our clients who all rely upon the success of their 340B programs to provide consistent patient care to their underserved communities. We are also proud to share our parent company’s values and mission. This is what sets Macro Helix apart from other Third-Party Administrators owned by PBMs, Insurance Companies, Retail Chains or private equity firms.

Yes, please contact us. Macro Helix sets forth a fee structure package that is very straightforward and competitive. Our fee structure is a known competitive advantage to us and has led to our continued success.